FDA Investigator Karen L Bauer
Karen L Bauer has inspections in 1 countries as of 14 Mar 2023. Karen L Bauer has collaborated with a combined 1755 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
34
Last Inspection Date:
14 Mar 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aaron J Adler,
Ademola O Daramola,
Alexandra B Pitkin,
Ana Djurdjevic,
Anderson,
Andrews,
Angela Shepas,
Anthony G Emerson,
Arsen Karapetyan,
Beau R Lamb,
Binh T Nguyen,
Bowman,
Bryan A Galvez,
Carr Sharpe,
Caryn M Mcnab,
Cathryn M Groehnert,
Celena Ngo,
Charles L Larson,
Christina D Mello,
Davis,
Deborah A Greco,
Deborah W Hsu,
Debra J Fracassa,
Dejon N Harris,
Desiree C Iya,
Donna Ltartaglino Besone,
Durell L Giles,
Dyana K Stone,
Eileen T Dupont,
Ellen N Stewart,
Garciam,
Gene D Arcy,
Greg K Keshishyan,
Harperd,
Henry E Carrillo,
Herminio C Francisco,
Hoover,
Hugh Grimoldby,
James A Barreto,
James D Planchon,
James R Fleckenstein,
Janet Pulver,
Jeannie Pradyanata,
Jeff M Uriarte,
Jennifer Crumb,
Jennifer M Gogley,
Jocelyn E Massey,
Joey V Quitania,
John A Daubenspeck,
John A Liu,
Joseph H Lam,
Juanita Banuelos,
Jude C Dikes,
Judy C Nepsa,
Julian C Hanson,
Ka L Wong,
Katherine E Jacobitz,
Kelvin Cheung,
Kevin T Gerrity,
Kimberly M Lichter,
Kirtida Patel,
Leonard H Lavi,
Lilly O Barton,
Liming Zhang,
Ling Yul Liu,
Lisa A Warner,
Mei Chen Mu,
Michael D Garcia,
Michael D Kawalek,
Michael S Araneta,
Michael S Call,
Minh D Phan,
Natalie J Ayoub,
Naveen B Walker,
Norman Wong,
Ounchith J Phabmixay,
Patricia F Alberico,
Patrick R Dimapindan,
Richard G Fochesato,
Richard W Tubb,
Robert C Hoover,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Sara Jdent Acosta,
Scott J Matsuda,
Scott K Zika,
Sean P Desbrow,
Selene T Torres,
Sonia R Peterson,
Sonya L Karsik,
State Agency,
Sundy V Sedwick,
Tamala P Magee,
Terrance L Thomas,
Thanh M Andrews,
Thao T Kwan,
Trudy R Papson,
Truong Xuan Nguyen (Andy),
Trushani T Desai,
Vickie L Anderson,
Victor H Loo,
Virgilio F Pacio, CSO,
William D Boden,
William S Vitale,
Yvette Mlacour Davis,
Yvonne T Lacour
Karen L Bauer's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2010 | EIR | Advanced Sterilization Products - EIR, 2010-12-17 |
May, 2011 | EIR | Integra Biotechnical LLC - EIR, 2011-05-24 |
October, 2009 | FDA 483 | Branan Medical Corporation - Form 483, 2009-10-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more